Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The bone marrow microenvironment, particularly stromal cells, plays a crucial role in cancer progression and treatment resistance.
• Intercellular communication between stromal and leukemic cells significantly contributes to therapy resistance in acute myeloid leukemia (AML).

Purpose of the Study:

• To elucidate the molecular mechanisms by which bone marrow stromal cells mediate therapy resistance in AML.
• To identify specific molecular players involved in stromal cell-induced drug resistance in AML.

Main Methods:

• Investigated the role of microRNA-23a-5p (miR-23a-5p) in stromal cell-leukemic cell interactions.
• Analyzed the impact of miR-23a-5p downregulation on autophagy pathways and Toll-like receptor 2 (TLR2) expression in AML cells.
• Evaluated the efficacy of autophagy inhibitors as adjunct therapy in AML models.

Main Results:

• Stromal cells were found to downregulate miR-23a-5p levels in AML cells, conferring protection against chemotherapy-induced apoptosis.
• Reduced miR-23a-5p levels led to increased protective autophagy via targeting TLR2 expression in leukemic cells.
• Autophagy inhibitors demonstrated improved drug sensitivity in vitro and in vivo leukemia models.
• This resistance mechanism was predominantly observed in myeloid leukemia.

Conclusions:

• Bone marrow stromal cells modulate miRNA expression in leukemic cells, contributing to drug resistance and potential relapse.
• Targeting the stromal cell-mediated miR-23a-5p/autophagy axis presents a potential therapeutic strategy for overcoming AML drug resistance.
• The bone marrow microenvironment critically influences leukemic cell behavior and treatment response.